Offer - Urjas Oil for just ₹ 1 X
Paclipar is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Breast Cancer. Paclipar also has some secondary and off-label uses. These are listed below.
The right dosage of Paclipar depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Paclipar as well, which are listed below. Usually, these side effects of Paclipar go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Paclipar's effect during pregnancy is Severe and Severe while nursing. Warnings related to Paclipar's effects on the liver, heart and kidney, if any, have been listed below.
Paclipar is contraindicated in people with pre-existing medical conditions like Liver Disease, Herpes, Heart Disease as it can result in adverse effects. The section on Paclipar contraindications lists all such conditions.
Additionally, Paclipar may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Paclipar is considered not safe while driving, and is not addictive.
Paclipar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Paclipar safe for pregnant women?
Paclipar should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Paclipar safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Paclipar. So it is adviced to consult the doctor before using it.
What is the effect of Paclipar on the Kidneys?
Paclipar is completely safe for kidneys.
What is the effect of Paclipar on the Liver?
Paclipar can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Paclipar on the Heart?
Paclipar has very mild side effects on the heart.
Paclipar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Paclipar unless your doctor advises you to do so -
Is this Paclipar habit forming or addictive?
No, you will not get addicted to Paclipar.
Is it safe to drive or operate heavy machinery when consuming?
After taking Paclipar, you should not drive or work on any heavy machine, as Paclipar can make you drowsy.
Is it safe?
Paclipar should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Paclipar for mental disorders.
Interaction between Food and Paclipar
Taking Paclipar with food does not harm your health.
Interaction between Alcohol and Paclipar
Taking alcohol with Paclipar can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 967-969
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 865-866
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Taxol® (paclitaxel)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user;Abraxane® (paclitaxel protein-bound particles)